Sincizial Virus: Also in Italy a New Monoclonal Antibody to Protect Newborns

Corriere Della Sera

Center

Factuality

Ownership

The options of prevention against this infection, responsible for bronchiolitis and lungitis in the youngest, are extended. Experts explain who is targeted, when to give it and why it is important to immunize infants.

notizie.it

canaledieci.it

View article

Reposted by

canaledieci.it

Factuality

Ownership

(Adnkronos) - After the approval of Aifa, the Italian Agency of the drug, comes to Italy clesrovimab for the prevention of the disease of the tract

Sassuolo 2000

Quotidiano Nazionale

View article

Reposted by

Quotidiano Nazionale

Factuality

Ownership

News Sassuolo - Sassuolo2000 daily online - news today sassuolo

Il Quotidiano del Sud

newsbiella.it

View article

Reposted by

newsbiella.it

Factuality

Ownership

A monoclonal antibody to prevent ROME disease (ITALPRESS) arrives in Italy after the approval of the Italian Medicines Agency (AIFA), clesrovimab for the prevention of lower respiratory tract disease from syncial respiratory virus (RSV) in infants at birth or during their first RSV season. Clesrovimab is contraindicated in infants with hypersensitivity to the active substance or to any of its [...] The South Daily. RSV, arrives in Italy a monocl…

italpress.com

Factuality

Ownership

ROME (ITALPRESS) - The new monoclonal antibody of MSD for the prevention of RSV, one of the most common seasonal infections and one of the main causes of hospitalization in the first few months of life, with a deep impact on [...]